Overview A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Status: RECRUITING Trial end date: 2026-11-01 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the efficacy and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy.Phase: PHASE3 Details Lead Sponsor: Shandong Suncadia Medicine Co., Ltd.